BK announced they signed MOU with US vaccine R&D firm Nugenerex Immuno-Oncology (Generex) to fund & manage development of peptide based vaccine for use against pandemic viruses such as covid-19
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
CharKuayTeow
7 posts
Posted by CharKuayTeow > 2020-08-17 20:01 | Report Abuse
partnership w US firm is out, we all know what this means for tmr!!